Ting Fang Cao
Presidente en Zensun (Shanghai) Sci & Tech Co., Ltd. .
Perfil
Ting Fang Cao is currently the Chairman-Supervisory Board & Legal Director at Zensun (Shanghai) Sci & Tech Co., Ltd.
She graduated from East China Normal University with an undergraduate degree in 2000.
Cargos activos de Ting Fang Cao
| Empresas | Cargo | Inicio |
|---|---|---|
Zensun (Shanghai) Sci & Tech Co., Ltd.
 Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | Presidente | 01/10/2015 |
Formación de Ting Fang Cao.
| East China Normal University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | Health Technology |
- Bolsa de valores
- Insiders
- Ting Fang Cao